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In September 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV testing for all Americans
aged 13–64, which would eliminate requirements for written consent and pretest counseling as previously required. However,
this approach may conflict with state requirements concerning pretest counseling and informed consent for HIV testing. Our
survey of state HIV testing laws demonstrates that the majority of states have HIV testing requirements that are inconsistent
with the CDC’s recommendations. Moreover, states that have recently amended their laws have not eased the requirements for
pretest counseling and informed consent. The reasons for the persistence of these legal requirements must be understood to
effect policy changes to increase HIV testing.
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INTRODUCTION
In September 2006, the Centers for Disease Control and
Prevention (CDC) recommended routine HIV testing for all
Americans between 13 and 64. According to the CDC’s
recommendations, routine HIV testing means that all patients
would be told that HIV testing is a routine part of care and they
will be tested unless they decline [1]. The CDC specifically
recommends eliminating requirements for specific consent to HIV
testing and pretest counseling, a significant departure from
previous HIV testing policy [1,2].
The CDC’s new recommendations are aimed at increasing the
number of people who know their HIV status to reduce transmission
[2–4]. People who are unaware they are HIV-infected account for
an estimated 20,000 new HIV infections annually [5]. People often
donottestfor HIV becausetheydonotperceive themselvesatriskof
infection [6–8]. Although patients are more likely to test when their
physicians suggest it [6,9], many physicians do not do so because
pretest counseling takes considerable time and discussing sexual and
drug behaviors that risk transmission may be uncomfortable
[10,11,12]. It is hoped that physicians will offer HIV testing more
often–and, thus, more people will test–if it is viewed as a routine part
ofcareand onlynotificationisrequired [1].Moreover,because there
is no assessment of sexual or drug-using risk, routine testing may
reduce the stigma of HIV testing [9]. Increasing HIV testing may
reduce transmission rates because people change their behaviors
when they know they are HIV-infected and because appropriate
HIV treatment can reduce viral load and thus decrease infectivity
[1,10,13]. It can also reduce morbidity by helping people who are
HIV-infected get appropriate treatment [10,13]. The CDC
recommends repeating testing at least annually for those at high
risk for HIV and asneeded based onclinical judgment for others [1].
Although there are costs to expanded testing, studies demonstrate
that routine HIV testing is a cost-effective means of achieving these
public health goals, even in low-prevalence populations [5,14].
Although there is widespread support for broader HIV testing,
HIV/AIDS advocates have expressed concerns about removing
protections such as written informed consent and pretest
counseling [15–19]. They argue that these processes are essential
to helping people understand the potential negative psychosocial
consequences of testing, particularly if results are positive, such as
stigma and discrimination [19–21]. Moreover, pretest counseling
is important to HIV prevention because it educates people about
reducing risk of infection, regardless of HIV-status [19–22]. In
addition, written consent for HIV testing protects patients and
physicians,whilepromotingpatientinformation and awareness [23].
The CDC and commentators have acknowledged that states’
laws might limit implementation of routine testing [1,4]; however,
none of the discussions have seriously addressed the extent of these
potential legal barriers. Because there is a national debate about
how to implement the CDC’s recommendations [24–26] and
some organizations already have begun implementation [17,27], it
is essential to understand how laws may affect these efforts. We
previously reported results of a survey of HIV testing statutes and
regulations in the 50 states and the District of Columbia in
connection with recommendations for routine HIV testing of
pregnant women that documented legal barriers to implementa-
tion of those recommendations [28]. For this article, we updated
our previous legal research to determine whether states have
changed their HIV testing laws to make it feasible to implement
routine testing. In particular, we looked at whether states had laws
or regulations that required pretest counseling or specific consent
to HIV testing and, if so, whether the laws specified the content of
the pretest counseling or informed consent. To better understand
these laws in context, we first provide background on existing HIV
testing policies.
The development of special HIV testing procedures
In 1985, when a test for HIV first became available, there was little
incentive for patients to be tested. The risks of being identified as
HIV-infected were serious, with people with AIDS being
discriminated against in housing, employment, insurance, and
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AIDS. Because there were no effective treatments for AIDS, the
personal benefits of testing were limited to planning for one’s own
future and taking steps to avoid transmission to others [2–4].
Nevertheless, public health officials sought to encourage HIV
testing with the expectation that if people knew their status, they
might alter their behavior. Those who received a negative test
might be more motivated to take precautions to avoid infection.
Those who received a positive test might take steps to avoid
transmitting the virus. To encourage testing, special procedures
were recommended to protect those who tested. Although
physicians have a legal and ethical obligation to obtain consent
for medical tests and treatment, in practice many medical
interventions are undertaken with verbal consent and may not
be specific [29]. For HIV, it was recommended that testing should
be conducted only with specific consent, preferably in writing. In
addition, testing should occur only after counseling; additional
counseling should accompany disclosure of test results. HIV test
results should receive special confidentiality protections beyond
those ordinarily given to medical information. People could also
test anonymously at separate test sites. Many states codified these
procedures into law [2–4].
METHODS
We identified relevant statutes and regulations using electronic legal
databases. We searched for laws in each state that addressed HIV
testing in medical care. Search terms included ‘‘human immunode-
ficiency,’’ ‘‘HIV,’’ ‘‘acquired immunodeficiency,’’ ‘‘AIDS,’’ and
‘‘test’’ and its variants. In particular, we searched for amendments to
HIV testing laws that were subject to our previous report [28]. We
analyzed the content of statutes according to their plain meaning, in
accordance with legal standards.
RESULTS
Our analysis of state laws regarding HIV testing demonstrates that
the policies adopted early in the epidemic to encourage testing
mostly remain in place today. We summarize relevant state
requirements for HIV testing as follows:
Requirements for informed consent and pre-test
counselling
We found that the majority of states have laws that require specific
consent for HIV testing. Fourteen states require written informed
consent. Nineteen states permit oral consent, though 5 of these
require consent to be documented. Eleven states require pretest
counseling–2 of which require counseling take place face-to-face.
Information disclosure
We found that 24 states require disclosure of specific information
during pretest counseling and/or the informed consent process.
Three of these states also recommend that additional information
be disclosed with the required disclosures. States vary considerably
in the amount of information they require to be disclosed, ranging
from 1 required topic (4 states) to 9 required topics (3 states), with
an average of approximately 5 topics. Table 1 summarizes the
topics that states require or recommend be disclosed during pretest
counseling and/or informed consent before HIV testing. Only one
state specifies that such disclosures are not required for people who
have previously tested and decline the information [30].
Only one state that amended its statutes since 2004 made
changes to facilitate implementation of routine testing, and that
was for prenatal testing, where there have been strong recom-
mendations to do so since 1998 [31–33]. The remainder retained
existing requirements. For example, one state that amended its
prenatal testing laws retained requirements for pretest counseling,
including disclosure of specific information [34]. Another state that
amended its prenatal HIV testing law continues to require written
consent, despite endorsing the IOM’s recommendations for
routine testing with notification and opt-out [35]. We found
similar trends in four states that changed their general HIV testing
laws. One of these was introduced and adopted after the CDC’s
recommendations were reported. The amended statute ties state
recommendations on HIV testing to the CDC’s ‘‘most current
guidelines,’’ but it explicitly rejects essential components of the
recommendations, stating that the CDC’s guidelines ‘‘shall in no
event be interpreted or implemented in a manner inconsistent with
the minimum informed consent standards of this [statute] [36].’’
Two of the other states changed their laws to require more
information to be conveyed during the consent process than they
previously required [37,38].
DISCUSSION
There is general agreement that we must increase HIV testing and
decrease the number of people who are unaware they are HIV-
infected. The CDC recommends routine HIV testing as one way
to achieve this goal. Although its recommendations may be
influential, the CDC does not have the authority to impose them
Table 1. Information to be disclosed in pretest counseling and/or informed consent for HIV testing
..................................................................................................................................................
Topic No. states require topic No. states recommend topic
The nature of the HIV test 20 1
HIV risk behaviors and prevention measures 12 1
Confidentiality/exceptions to confidentiality of HIV test 12 0
That testing is voluntary 11 1
That anonymous testing is available 10 0
The nature of HIV/AIDS 8 2
Right to withdraw consent for HIV testing 8 1
The risks/benefits of HIV testing 7 1
The availability of referrals for information about or treatment for HIV 4 0
How HIV test results may be used 3 0
How HIV testing may affect the ability to obtain services 1 0
doi:10.1371/journal.pone.0001005.t001
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government, and all other powers are reserved to the states [39].
The regulation of health and public health are commonly
recognized as state issues [40]. Accordingly, states hold the
ultimate authority for HIV testing policy.
We found significant legal barriers to implementing the CDC’s
recommendations for routine HIV testing. Because of state
requirements for specific consent to HIV testing, written consent
to testing, and disclosure of specific information during pretest
counseling or the informed consent process, the majority of states
would need to amend their laws to permit routine HIV testing. For
example, states that require disclosures would need either to
eliminate those disclosures or make them recommendations,
rather than requirements. However, our findings show that
legislatures have not made the legal changes necessary to facilitate
more routine HIV testing, despite strong public health recom-
mendations to do so. In fact, the trend in states that have amended
their laws since 2004 has been to reaffirm requirements for pretest
counseling and consent, even, in some instances, while acknowl-
edging the recommendations for more routine testing.
Even states without HIV testing statutes may face legal barriers
to implementing the CDC’s recommendations for routine HIV
testing. Based on case law, many states use a ‘‘reasonable patient’’
standard for informed consent to medical treatment; physicians
must disclose what a patient with ordinary reason and intelligence
would want to know in making a medical decision. Because policy
has recommended specific consent to HIV testing after pretest
counseling and due to continued stigma surrounding HIV, it is
likely that the ‘‘reasonable patient’’ standard would require more
information about HIV testing than is currently contemplated
under the CDC’s recommendations. It may take time–and
education efforts–to change public perceptions and to make
routine testing acceptable.
Understanding these legal barriers and the apparent resistance
to changing state HIV testing policies is essential to effecting any
policy change that might increase HIV testing. The legislative
history is sparse, but press reports suggest that the concerns that
led to the adoption of special HIV testing legislation still resonate
today. For example, legislators and HIV advocates have expressed
concerns that the very limited disclosures that the CDC
recommends are insufficient for making informed decisions about
testing [22,23,41]. They suggest that additional procedures are still
necessary for HIV testing because of the potential serious and
negative effects, such as stigma and discrimination, that may be
associated with HIV testing and infection [21,23,41,42]. Some
contend that the risks are greater because states now require
names-based HIV reporting [21]. There is some evidence to
support these concerns.
While the risks and benefits of testing have changed sub-
stantially with the advent of antiretroviral treatment [4], people
living with HIV are still victims of discrimination, violence, and
other social harms. Twenty to twenty-five percent of people living
with HIV report experiencing discrimination in medical care and
employment [43–47]. A study of discrimination claims filed with
the Equal Employment Opportunity Commission (EEOC) sup-
ports these self-reports, finding HIV/AIDS-related employment
discrimination to be ‘‘the most pervasive in terms of the number
and magnitude of differences’’ and ‘‘particularly prevalent and
conspicuous’’ compared to ‘‘a general disability population’’ [44].
In populations that already are subject to stigma or discrimination,
including men who have sex with men and ethnic minorities, the
risks of HIV testing may be higher [44]. Appreciating these
psychosocial risks may be essential to making an informed decision
about testing.
Eliminating pretest disclosures and counseling may also remove
an important mechanism for educating individuals about HIV and
reducing risk [21,48]. Prevention remains the best strategy against
HIV. Research has previously demonstrated that counseling is
effective in helping people change their behaviors to prevent
transmission of HIV [49,50]; moreover, even brief, client-centered
risk reduction counseling reduced both HIV risk behavior [49]
and STD incidence [49,51] compared to didactic informational
prevention messages. Given that a major rationale for the CDC’s
revised recommendations is to detect HIV infection in individuals
who either have never tested before, or who avoid retesting despite
engaging in risk behavior, the need for pretest disclosures and
counseling may be more important than ever, at least in the short
term.
Another potential unintended consequence of these recommen-
dations is that they may weaken protections, without substantially
increasing testing among those who are unaware they are HIV-
infected. The voluntary testing literature suggests access to a regular
health care provider (HCP) and possession of health insurance
predict test-seeking [7,52–58]. Therefore, detection of HIV among
those without a regular HCP or insurance may continue to prove
challenging even if routine testing were implemented. In addition,
a pattern of delayed or avoided testing among lower-income, less-
educated, and ethnic minority populations is also found in the
literature [7,9,56,59]. It is possible that lack of access to HCP and
health insurance, as well as inaccurate perceptions of individual- and
community-level risk for HIV infection may be concentrated at this
end of the socioeconomic spectrum. Finally, increasing the number
of individuals in this sub-population who know their HIV-positive
status may only serve to increase their social vulnerability. Specific
interventions that provide support to socially vulnerable HIV-
positive individuals may be required before this policy recommen-
dation can be fully implemented.
These are important considerations, and developing a deeper
understanding of them may suggest policy alternatives that may be
more broadly acceptable, while achieving the important public
health goal of increasing HIV testing. For example, written
consent may be beneficial as a reminder to clinicians of their
obligations to obtain specific consent to HIV testing and as
a deterrent to unconsented testing. But documenting consent in
the medical chart might be a viable alternative to written consent
[48]. Similarly, it may be that not all of the information disclosed
during pretest counseling and the informed consent process is
essential to sound decision-making or that some of it could be
conveyed in writing, rather than orally [42]. Flexibility in
requirements may allow procedures to be appropriately tailored–
for example, to distinguish between people testing for the first time
and those who are repeat testers.
Successful examples of implementing more routine testing
without abandoning specific consent exist. For example, the
emergency department (ED) at Highland Hospital, an urban,
academic teaching hospital in the San Francisco Bay Area, studied
the feasibility of routinely offering HIV testing to patients. It used
a combined approach of providing written information, using
posters about HIV testing in the ED and informational brochures
to answer basic questions about HIV, and clinician interactions.
Triage nurses ask patients whether they are interested in testing,
using a specially designed consent form and a script. Similarly, the
Adolescent AIDS Program at Children’s Hospital at Montefiore
Medical Center in New York sought to make HIV testing more
routine in heath care services. They developed a protocol to help
providers increase testing, which includes a pocket guide for
providers, a poster promoting routine HIV testing, patient HIV
education brochures, and a substantial shortening of the time for
Routine HIV Testing
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community health clinics showed a doubling of testing among
the intervention sites [24].
More public discussion of the CDC’s recommendations is
needed. Although the CDC sought public input into its
recommendations, some HIV/AIDS advocacy organizations
complained that the process was inadequate [20,22]. Different
stakeholders–public health and medical professionals, HIV
advocates, and legislators – come to the debate with different
perspectives. These perspectives must be taken into account if we
are to develop an HIV testing policy that is generally acceptable
and implementable. Moreover, many organizations already are
looking at how to implement the recommendations in the clinical
setting and elsewhere [24,25,27]. One of these reports an increase
in testing under new procedures [27]. However, these organiza-
tions may not understand how state laws may limit their ability to
implement the CDC recommendations. Potentially, these organi-
zations could be in legal jeopardy for following the CDC’s
recommendations, but violating state law.
In sum, the CDC’s recommendations for routine HIV testing
represent an important change in the public health approach to
HIV. However, states are ultimately responsible for implementing
HIV testing policy, and individual states may have different
concerns. More attention needs to be focused on understanding
why states appear to have been reluctant to adopt HIV testing
policies that permit more routine testing and to develop policy
options that will be acceptable to them.
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